Top Markets
#1 Black Phoenix Black Phoenix +736.30%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.03%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +18.96%
#4 MetaDAO MetaDAO +16.19%
#5 Verus Coin Verus Coin +13.88%
#6 THORChain THORChain +9.02%
#7 PondCoin PondCoin +8.70%
#8 Akedo Akedo +8.63%
#9 Prom Prom +7.96%
#10 Biconomy Biconomy +7.63%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Xiamen Amoytop Biotech Co., Ltd. Xiamen Amoytop Biotech Co., Ltd.

Xiamen Amoytop Biotech Co., Ltd.

688278
Rank in Stocks #4564
Xiamen Amoytop Biotech Co., Ltd. specializes in the creation,... Xiamen Amoytop Biotech Co., Ltd. specializes in the creation, commercialization, and distribution of biopharmaceutical products within China, utilizing advanced genetic engineering techniques. Its offerings span a variety of pharmaceutical goods, including finished drug formulations, diagnostic reagents, and active pharmaceutical ingredients (APIs). The company further extends its services to include bespoke contract manufacturing. Founded in 1996, the firm is headquartered in Xiamen, China.
Share Price
$8.58
Market Cap
$3.50B
Change (1 day)
-1.35%
Change (1 year)
-25.53%
Country
CN
Trade Xiamen Amoytop Biotech Co., Ltd. (688278)

Category

Healthcare
P/E ratio for Xiamen Amoytop Biotech Co., Ltd. (688278)
P/E ratio as of 2026 TTM: 0
According to Xiamen Amoytop Biotech Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Xiamen Amoytop Biotech Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.